期刊文献+

奥沙利铂联合三维适形放疗治疗老年晚期食管癌的临床观察 被引量:2

The Clinical Observation of Oxaliplatin Combined with Three Dimensional Conformal Radiation Therapy in the Treatment of the Elderly Patients with Advanced Esophageal Carcinoma
下载PDF
导出
摘要 目的观察奥沙利铂联合三维适形放疗治疗老年晚期食管癌的疗效和毒副反应。方法 80例老年晚期食管癌随机分为两组,试验组给予奥沙利铂化疗和三维适形放疗,而对照组仅给予三维适形放疗。治疗结束后两组分别评价疗效和毒副反应。结果试验组有效率为90.0%,对照组为72.5%,差异有统计学意义(P<0.05)。试验组和对照组1、2、3年生存率分别为56.5%、31.5%、22.0%和48.5%、28.5%、18.0%,差异均无统计学意义(P>0.05)。两组毒副反应发生率均较低,且均为轻度,但试验组的神经毒性发生率较对照组高(P<0.05)。结论奥沙利铂联合三维适形放疗治疗老年晚期食管癌能明显提高近期疗效,且毒副反应可耐受。 Objective To observe the efficacy and toxicities of oxaliplatin combined with three dimensional conformal radiation therapy in the treatment of the elderly patients with advanced esophageal carcinoma.Methods All the 80 elderly patients with advanced esophageal carcinoma were randomly divided into two groups.The 40 patients in the trial group received oxaliplatin and three dimensional conformal radiation therapy;the 40 patients in the control group received three dimensional conformal radiation therapy.The efficacy and toxicities were evaluated after treatment.Results The response rate was 90.0% in the trial group,and was 72.5% in the control group(P0.05).The 1-,2-and 3-year survival rates were 56.5%,31.5%,22.0% in the trial group,and were 48.5%,28.5%,18.0%in the control group(P0.05).The incidences of common toxicities of the two groups were low,and the toxicities were light;but the incidence of neurotoxicity in the trial group was higher than that of the control group(P0.05).Conclusion Oxaliplatin combined with three dimensional conformal radiation therapy can improve the short term efficacy of the elderly patients with advanced esophageal carcinoma,and its toxicities are tolerable.
出处 《肿瘤基础与临床》 2011年第2期117-118,共2页 journal of basic and clinical oncology
关键词 奥沙利铂 三维适形放疗 晚期食管癌 oxaliplatin three dimensional conformal radiation therapy elderly patients advanced esophageal carcinoma
  • 相关文献

参考文献4

二级参考文献18

  • 1周际昌.实用肿瘤内科学[M].北京:人民卫生出版社,1998.331.
  • 2Seitz JF,Giovannini M,Padaut-Cesama J,et al.Inoperable nonmetastatic squamous cell carcinoma of the esophagus managed by concomitant chemotherapy (5-fluorouracil and cisplatin) and radiation therapy[J].J Cancer,1990,66 (2):214-219.
  • 3Al-Sarraf M,Martz K,Herskovic A,et al.Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer:an intergroup study[J].J Clin Oncol,1997,15(1):277-284.
  • 4Asakura H,Takashima H,Yokoe K,et al.Hyperfractionated radiotherapy with concurrent chemotherapy for advanced esophageal cancer[J].Gan To Kagaku Ryoho,2005,32(9):1279-1282.
  • 5Zhao KL,Shi XH,Jiang GL,et al.Late course accelerated hyperfractionated radiotherapy plus concurrent chemotherapy for squamous cell carcinoma of the esophagus:a phase Ⅲ randomized study[J].Int J Radiat Oncol Biol Phys,2005,62 (4):1014-20.
  • 6Steel CG,Peckham M J,Exploitable mechanisms in combined radiotherapy-chemotherapy:the concept of additivity[J].Int J Radiat Oncol Biol Phys,1970,5(1):85-91.
  • 7Diehl LF.Radiation and chemotherapy in the treatment of esophageal cancer[J].Gastroenterol Clin North Ame,1991,20 (4):765 -774.
  • 8Katlic MR,Wilkins EW Jr,Grillo HC.Three decades of treatment of esophageal squamous carcinoma at the Massachusetts General Hospital[J].J Thorac Cardiovasc Surg,1990,99 (5):929-938.
  • 9Kelsen D.Multmodality therapy for adenocarcinoma of the esophagus[J].Gastroenterol Clin North Am,1997,26 (3):635-645.
  • 10Cooper JS,Guo MD,Herskovic A,et al.Chemoradiotherapy of locally esophageal cancer:long-term follow-up of a prospective randomized trial (RTOG 8501).Radiation Therapy Oncology Group[J].JAMA,1999,281 (17):1623-1627.

共引文献113

同被引文献6

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部